The latest research study “Electrocardiograph (ECG) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global electrocardiograph (ECG) market size reached US$ 8.76 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 12.31 Billion by 2027, exhibiting a growth rate (CAGR) of 5.70% during 2022-2027.

An electrocardiograph (ECG) records the electric activity of the heart by measuring its surface potentials. With this painless, noninvasive process, it is possible to diagnose heart issues, including arrhythmias and coronary artery disease, and the effectiveness of certain heart disease treatments.

By conducting surface potentials from metal contacts, also called electrodes to an instrument, the electrical activity of the heart can be measured on the surface of the skin. A machine that measures ECGs is connected to these electrodes through cables that are placed on the chest, lower arms, and calves. ECG graphs are generated by the machine via the conversion of signals, whereas in some cases, they can also be printed.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. 

Request a free sample brochure:

Electrocardiograph (ECG) Market Trends and Drivers: 

The growing prevalence of cardiovascular diseases, including ischemic heart disease (IHD), hypertensive heart disease, stroke, and peripheral artery diseases is among the key factors stimulating the electrocardiograph (ECG) market, the expanding geriatric population who are more susceptible to developing these diseases is positively influencing the global market.

The numerous technological advancements in ECG devices, such as the introduction of innovative designs and additional features, are acting as significant growth-inducing factors, the launch of several favorable reimbursement policies by government bodies is also propelling the market growth. The inflating popularity of portable ECG systems and remote monitoring devices with a single lead is further propelling the market growth. Extensive R&D activities conducted by key market players to improve healthcare infrastructures are expected to drive the electrocardiograph (ECG) market over the forecasted period.

Author bio:

Hello, I am a professional SEO Expert & Write for us technology blog and submit a guest post on different platforms- we provide a good opportunity for content writers to submit guest posts on our website. We frequently highlight and tend to showcase guests.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

Electrocardiograph (ECG) Market Report Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

AliveCor Inc., Allengers Medical Systems Limited, BPL Medical Technologies, CompuMed Inc., Fukuda Denshi Co. Ltd., General Electric Company, Hill-Rom Holdings Inc. (Baxter International Inc.), Innomed Medical Inc., Koninklijke Philips N.V., Midmark Corporation, Nihon Kohden Corporation, OSI Systems Inc., Schiller AG and Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

The report has been segmented the market into following categories:


  • Resting Electrocardiograph (ECG)
  • Stress Electrocardiograph (ECG)
  • Holter Monitors
  • Others

Lead Type:

  • Single Lead ECG
  • 2 Lead ECG
  • 3 Lead ECG
  • 6 Lead ECG
  • 12 Lead ECG

End User:

  • Hospitals and Clinics
  • Home Settings and Ambulatory Surgical Centers (ASCs)
  • Others

By Geography:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800